Heart Failure Forum-1
|
08:00-10:00 103A |
|---|
| 主持 Moderators | 张健 Jian ZHANG, 叶红华 Honghua YE, 唐礼江 Lijiang TANG, Haoyi ZHENG, 谢小洁 Xiaojie XIE, 马宏 Hong MA | ||
|
08:00-08:20 |
AI赋能心衰治疗药物研发 AI-Enabled Drug Development for Heart Failure Therapy |
肖瑞平 Ruiping XIAO | |
|
08:20-08:40 |
心脏淀粉样变的诊治进展 Recent Advances in the Diagnosis and Treatment of Cardiac Amyloidosis |
张健 Jian ZHANG | |
|
08:40-09:00 |
达格列净在经导管主动脉瓣置换术后的应用（DapaTAVI试验） Dapagliflozin after Transcatheter Aortic Valve Implantation (the DapaTAVI Trial) |
Sergio Raposeiras ROUBIN | |
|
09:00-09:20 |
台湾地区心衰共识与注册登记研究结果 Heart Failure Consensus and Registry Findings in Taiwan |
Chung-Lieh HUNG | |
|
09:20-09:40 |
2025 ESC热点争议: B阻剂心梗后长期使用的循证探索 2025 ESC Hotly Debated Topics: Evidence-Based Exploration of Long-Term Beta-Blocker Use Post-Myocardial Infarction |
侯爱洁 Aijie HOU | |
|
09:40-10:00 |
简化滴定相关新研究 Novel Evidence Regarding Simplified Titration Strategies |
戴翠莲 Cuilian DAI | |
|
10:00-12:00 103A |
|---|
| 主持 Moderators | Harlan KRUMHOLZ, Filippo CREA, 王建安 Jianan WANG, Yuan LU, 赵冬 Dong ZHAO, 李希 Xi LI | ||
|
10:00-10:20 |
The Burden of Cardiovascular Disease in China: Incidence Estimates from National Surveillance (2023) | 王增武 Zengwu WANG | |
|
10:20-10:40 |
Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single de Novo Diffuse Coronary Lesions | Eun-Seok SHIN | |
|
10:40-11:00 |
Non-invasive Focused Power Ultrasound Therapy Targeting Inferior Perirenal Adipose Tissue for Drug Naive Hypertension: A Randomized, Sham-controlled, Proof-of-concept Trial (PARADISE-HTN-II) | 孔祥清 Xiangqing KONG | |
|
11:00-11:20 |
Dynamic Changes of 3D Bending Angle Through the Cardiac Cycle: Implications With Bioresorbable Scaffold Performance | 涂圣贤 Shengxian TU | |
|
11:20-11:40 |
Antispastic Therapy after Coronary Artery Bypass Surgery with Radial Artery Grafts: Four-Year Follow-Up of Randomised ASRAB-Pilot Trial | 朱嘉希 Jiaxi ZHU | |
|
11:40-12:00 |
Long-Term Efficacy and Safety of SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia | 谢小洁 Xiaojie XIE | |
|
13:30-15:30 103A |
|---|
| 主持 Moderators | Sergio Raposeiras ROUBIN, Myeong-Ki HONG, Jeehoon KANG, 陈绍良 Shaoliang CHEN, 杜昕 Xin DU, 朱云鹏 Yunpeng ZHU | ||
|
13:30-13:50 |
Endovenous Radiofrequency Ablation of Great Saphenous Varicose Vein: A Prospective Multicenter Randomized Controlled Study | 刘震杰 Zhenjie LIU | |
|
13:50-14:10 |
Prognostic Implications of Plaque and Hemodynamic Characteristics for Risk of Future Acute Coronary Syndrome According to Lesion Multiplicity | Seokhun YANG | |
|
14:10-14:30 |
Who Benefits from Angiography-derived FFR-Guided Revascularization? Defining the Beneficial Population and Its Key Features | 王浩宇 Haoyu WANG | |
|
14:30-14:50 |
Real-time Evaluation and Anticipation of Causal disTillation Early Prediction for Cardiac Surgery-Associated Acute Kidney Injury (REACT-01) : a Single-Center Prospective Randomized Clinical Trial | 姜艺 Yi JIANG | |
|
14:50-15:10 |
Mortality Risk Stratification Using Electrocardiogram-Based Machine Learning for Patients in the Emergency Department | 陈静 Jing CHEN | |
|
15:10-15:30 |
Efficacy and Safety of Alpha-Lipoic Acid in Patients with Ischemic Heart Failure: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study | 孙爱军 Aijun SUN | |
Ventricular Arrhythmia Forum
|
15:30-17:10 103A |
|---|
| 主持 Moderators | 吴书林 Shulin WU, 李岳春 Yuechun LI, 常栋 Dong CHANG, 蔡哲钧 Zhejun CAI | ||
|
15:30-15:50 |
经心包途径的室性心律失常消融细节与常见问题 The Pericardial Approach for Ventricular Tachycardia Ablation: Key Technical Details and Common Challenges |
龙德勇 Deyong LONG | |
|
15:50-16:10 |
器质性室速的机制探索与消融策略 Mechanisms and Ablation Strategies for Ventricular Tachycardia in Structural Heart Disease |
李广平 Guangping LI | |
|
16:10-16:30 |
PFA技术在室性心律失常消融中的应用探索 Exploring the Application of Pulsed Field Ablation in Catheter Ablation of Ventricular Arrhythmias |
蔡铖 Cheng CAI | |
|
16:30-16:50 |
Catheter Ablation for Ventricular Arrhythmias in Inherited Arrhythmic Syndromes | Wataru SHIMIZU | |
|
16:50-17:10 |
讨论 Discussion |
||